L-arginine alleviates doxorubicin-induced endothelium-dependent dysfunction by promoting nitric oxide generation and inhibiting apoptosis. (1st July 2019)
- Record Type:
- Journal Article
- Title:
- L-arginine alleviates doxorubicin-induced endothelium-dependent dysfunction by promoting nitric oxide generation and inhibiting apoptosis. (1st July 2019)
- Main Title:
- L-arginine alleviates doxorubicin-induced endothelium-dependent dysfunction by promoting nitric oxide generation and inhibiting apoptosis
- Authors:
- Li, Xunan
Gu, Jie
Zhang, Yunlong
Feng, Siting
Huang, Xin
Jiang, Yinong
Xia, Yunlong
Liu, Yang
Yang, Xiaolei - Abstract:
- Abstract: Background/aims: Patients with doxorubicin (Dox) treatment have a high risk of developing vascular toxicity with an unknown mechanism.l -arginine is a substrate for nitric oxide (NO). The decreased level of arginine-NO metabolite in Dox-treated cancer patients was associated with increased level of vascular damage, which promoted us to investigate the mechanism of Dox-induced vascular dysfunction and verify whetherl -arginine supplement could alleviate this vasculotoxic effect. Method: Within a mouse model of Dox injection (5 mg/kg i.p., 2 or 4 weeks), we measured vascular relaxation, blood pressure, vascular NO generation, apoptosis, and oxidative stress. We tested the efficacy ofl -arginine (1.5 mg/g/day, 4 weeks) on Dox-induced vascular relaxation, blood pressure, vascular NO generation, apoptosis, as well as oxidative stress. Results: Dox induced endothelium-dependent vascular dysfunction, which was associated with increased reactive oxidative stress (ROS) production and reduced NO generation in the vessel. ROS was required for Dox-induced apoptosis of both smooth muscle cells and endothelial cells. Dox treatment in mice increased blood pressure, but had no effect on vascular inflammation and fibrosis. L-aringine restored Dox-induced vascular dysfunction via enhancing vascular NO production and alleviating ROS-mediated apoptosis. Conclusion: We for the first time demonstratedl -arginine was effectively in suppressing Dox-induced vascular dysfunction, byAbstract: Background/aims: Patients with doxorubicin (Dox) treatment have a high risk of developing vascular toxicity with an unknown mechanism.l -arginine is a substrate for nitric oxide (NO). The decreased level of arginine-NO metabolite in Dox-treated cancer patients was associated with increased level of vascular damage, which promoted us to investigate the mechanism of Dox-induced vascular dysfunction and verify whetherl -arginine supplement could alleviate this vasculotoxic effect. Method: Within a mouse model of Dox injection (5 mg/kg i.p., 2 or 4 weeks), we measured vascular relaxation, blood pressure, vascular NO generation, apoptosis, and oxidative stress. We tested the efficacy ofl -arginine (1.5 mg/g/day, 4 weeks) on Dox-induced vascular relaxation, blood pressure, vascular NO generation, apoptosis, as well as oxidative stress. Results: Dox induced endothelium-dependent vascular dysfunction, which was associated with increased reactive oxidative stress (ROS) production and reduced NO generation in the vessel. ROS was required for Dox-induced apoptosis of both smooth muscle cells and endothelial cells. Dox treatment in mice increased blood pressure, but had no effect on vascular inflammation and fibrosis. L-aringine restored Dox-induced vascular dysfunction via enhancing vascular NO production and alleviating ROS-mediated apoptosis. Conclusion: We for the first time demonstratedl -arginine was effectively in suppressing Dox-induced vascular dysfunction, by attenuating vascular NO release and apoptosis. Our results provide a therapeutic target or a circulating marker for assessing vascular dysfunction which response to Dox treatment, and advance our understanding of the mechanisms of Dox-induced vascular dysfunction. … (more)
- Is Part Of:
- Toxicology. Volume 423(2019)
- Journal:
- Toxicology
- Issue:
- Volume 423(2019)
- Issue Display:
- Volume 423, Issue 2019 (2019)
- Year:
- 2019
- Volume:
- 423
- Issue:
- 2019
- Issue Sort Value:
- 2019-0423-2019-0000
- Page Start:
- 105
- Page End:
- 111
- Publication Date:
- 2019-07-01
- Subjects:
- DAPI 4', 6-diamidino-2-phenylindole -- Dox doxorubicin -- eNOS endothelial nitric oxide synthase -- NAC N-acetyl-L-cysteine -- NO nitric oxide -- NOX NADPH oxidase -- ROS reactive oxidative stress -- SNP sodium nitroprusside -- TUNEL transferase-mediated dUTP nick end labeling
Doxorubicin -- l-arginine -- Vascular toxicity -- Reactive oxygen species -- Apoptosis
Toxicology -- Periodicals
Chemicals -- Physiological effect -- Periodicals
615.9005 - Journal URLs:
- http://www.sciencedirect.com/science/journal/0300483X ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.tox.2019.05.016 ↗
- Languages:
- English
- ISSNs:
- 0300-483X
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 8873.035000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 11027.xml